Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Growth 2025-2031
The report requires updating with new data and is sent in 48 hours after order is placed.
The global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs market size is predicted to grow from US$ 2197 million in 2025 to US$ 2855 million in 2031; it is expected to grow at a CAGR of 4.5% from 2025 to 2031.
Chemotherapy-induced nausea and vomiting (CINV) is a common side-effect of many cancer treatments. Nausea and vomiting are two of the most feared cancer treatment-related side effects for cancer patients and their families. In 1983, Coates et al. found that patients receiving chemotherapy ranked nausea and vomiting as the first and second most severe side effects, respectively. Up to 20% of patients receiving highly emetogenic agents in this era postponed, or even refused, potentially curative treatments. Since the 1990s, several novel classes of antiemetics have been developed and commercialized, becoming a nearly universal standard in chemotherapy regimens, and helping to better manage these symptoms in a large portion of patients. Efficient mediation of these unpleasant and sometimes crippling symptoms results in increased quality of life for the patient, and better overall health of the patient, and, due to better patient tolerance, more effective treatment cycles.
Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs key players include Merck, Eisai, Mundipharma, etc. Global top three manufacturers hold a share over 50%.
North America is the largest market, with a share about 50%, followed by China, and Europe both have a share about 35 percent.
In terms of product, 5-HT3 Inhibitors is the largest segment, with a share over 60%. And in terms of application, the largest application is Moderately Emetogenic Chemotherapy, followed by Highly Emetogenic Chemotherapy, Low Emetogenic Chemotherapy, etc.
LP Information, Inc. (LPI) ' newest research report, the “Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Industry Forecast” looks at past sales and reviews total world Chemotherapy Induced Nausea and Vomiting (CINV) Drugs sales in 2024, providing a comprehensive analysis by region and market sector of projected Chemotherapy Induced Nausea and Vomiting (CINV) Drugs sales for 2025 through 2031. With Chemotherapy Induced Nausea and Vomiting (CINV) Drugs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Chemotherapy Induced Nausea and Vomiting (CINV) Drugs industry.
This Insight Report provides a comprehensive analysis of the global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Chemotherapy Induced Nausea and Vomiting (CINV) Drugs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Chemotherapy Induced Nausea and Vomiting (CINV) Drugs and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs.
This report presents a comprehensive overview, market shares, and growth opportunities of Chemotherapy Induced Nausea and Vomiting (CINV) Drugs market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs market?
What factors are driving Chemotherapy Induced Nausea and Vomiting (CINV) Drugs market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Chemotherapy Induced Nausea and Vomiting (CINV) Drugs market opportunities vary by end market size?
How does Chemotherapy Induced Nausea and Vomiting (CINV) Drugs break out by Type, by Application?
The global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs market size is predicted to grow from US$ 2197 million in 2025 to US$ 2855 million in 2031; it is expected to grow at a CAGR of 4.5% from 2025 to 2031.
Chemotherapy-induced nausea and vomiting (CINV) is a common side-effect of many cancer treatments. Nausea and vomiting are two of the most feared cancer treatment-related side effects for cancer patients and their families. In 1983, Coates et al. found that patients receiving chemotherapy ranked nausea and vomiting as the first and second most severe side effects, respectively. Up to 20% of patients receiving highly emetogenic agents in this era postponed, or even refused, potentially curative treatments. Since the 1990s, several novel classes of antiemetics have been developed and commercialized, becoming a nearly universal standard in chemotherapy regimens, and helping to better manage these symptoms in a large portion of patients. Efficient mediation of these unpleasant and sometimes crippling symptoms results in increased quality of life for the patient, and better overall health of the patient, and, due to better patient tolerance, more effective treatment cycles.
Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs key players include Merck, Eisai, Mundipharma, etc. Global top three manufacturers hold a share over 50%.
North America is the largest market, with a share about 50%, followed by China, and Europe both have a share about 35 percent.
In terms of product, 5-HT3 Inhibitors is the largest segment, with a share over 60%. And in terms of application, the largest application is Moderately Emetogenic Chemotherapy, followed by Highly Emetogenic Chemotherapy, Low Emetogenic Chemotherapy, etc.
LP Information, Inc. (LPI) ' newest research report, the “Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Industry Forecast” looks at past sales and reviews total world Chemotherapy Induced Nausea and Vomiting (CINV) Drugs sales in 2024, providing a comprehensive analysis by region and market sector of projected Chemotherapy Induced Nausea and Vomiting (CINV) Drugs sales for 2025 through 2031. With Chemotherapy Induced Nausea and Vomiting (CINV) Drugs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Chemotherapy Induced Nausea and Vomiting (CINV) Drugs industry.
This Insight Report provides a comprehensive analysis of the global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Chemotherapy Induced Nausea and Vomiting (CINV) Drugs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Chemotherapy Induced Nausea and Vomiting (CINV) Drugs and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs.
This report presents a comprehensive overview, market shares, and growth opportunities of Chemotherapy Induced Nausea and Vomiting (CINV) Drugs market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- 5-HT3 Inhibitors
- NK1 Inhibitors
- Other
- Highly Emetogenic Chemotherapy
- Moderately Emetogenic Chemotherapy
- Low Emetogenic Chemotherapy
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Merck
- Eisai
- Mundipharma
- Qilu Pharma
- Teva
- Novartis
- Heron Therapeutics
- Roche
- Mylan
- Tesaro
What is the 10-year outlook for the global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs market?
What factors are driving Chemotherapy Induced Nausea and Vomiting (CINV) Drugs market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Chemotherapy Induced Nausea and Vomiting (CINV) Drugs market opportunities vary by end market size?
How does Chemotherapy Induced Nausea and Vomiting (CINV) Drugs break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Chemotherapy Induced Nausea and Vomiting (CINV) Drugs by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Chemotherapy Induced Nausea and Vomiting (CINV) Drugs by Country/Region, 2020, 2024 & 2031
2.2 Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Segment by Type
2.2.1 5-HT3 Inhibitors
2.2.2 NK1 Inhibitors
2.2.3 Other
2.3 Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Type
2.3.1 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Market Share by Type (2020-2025)
2.3.2 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue and Market Share by Type (2020-2025)
2.3.3 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sale Price by Type (2020-2025)
2.4 Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Segment by Application
2.4.1 Highly Emetogenic Chemotherapy
2.4.2 Moderately Emetogenic Chemotherapy
2.4.3 Low Emetogenic Chemotherapy
2.4.4 Other
2.5 Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Application
2.5.1 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sale Market Share by Application (2020-2025)
2.5.2 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue and Market Share by Application (2020-2025)
2.5.3 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Breakdown Data by Company
3.1.1 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Annual Sales by Company (2020-2025)
3.1.2 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Market Share by Company (2020-2025)
3.2 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Annual Revenue by Company (2020-2025)
3.2.1 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue by Company (2020-2025)
3.2.2 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Market Share by Company (2020-2025)
3.3 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sale Price by Company
3.4 Key Manufacturers Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Product Location Distribution
3.4.2 Players Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR CHEMOTHERAPY INDUCED NAUSEA AND VOMITING (CINV) DRUGS BY GEOGRAPHIC REGION
4.1 World Historic Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Size by Geographic Region (2020-2025)
4.1.1 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Size by Country/Region (2020-2025)
4.2.1 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Annual Sales by Country/Region (2020-2025)
4.2.2 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Annual Revenue by Country/Region (2020-2025)
4.3 Americas Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Growth
4.4 APAC Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Growth
4.5 Europe Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Growth
4.6 Middle East & Africa Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Growth
5 AMERICAS
5.1 Americas Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Country
5.1.1 Americas Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Country (2020-2025)
5.1.2 Americas Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue by Country (2020-2025)
5.2 Americas Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Type (2020-2025)
5.3 Americas Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Region
6.1.1 APAC Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Region (2020-2025)
6.1.2 APAC Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue by Region (2020-2025)
6.2 APAC Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Type (2020-2025)
6.3 APAC Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Chemotherapy Induced Nausea and Vomiting (CINV) Drugs by Country
7.1.1 Europe Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Country (2020-2025)
7.1.2 Europe Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue by Country (2020-2025)
7.2 Europe Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Type (2020-2025)
7.3 Europe Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Chemotherapy Induced Nausea and Vomiting (CINV) Drugs by Country
8.1.1 Middle East & Africa Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Country (2020-2025)
8.1.2 Middle East & Africa Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue by Country (2020-2025)
8.2 Middle East & Africa Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Type (2020-2025)
8.3 Middle East & Africa Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Chemotherapy Induced Nausea and Vomiting (CINV) Drugs
10.3 Manufacturing Process Analysis of Chemotherapy Induced Nausea and Vomiting (CINV) Drugs
10.4 Industry Chain Structure of Chemotherapy Induced Nausea and Vomiting (CINV) Drugs
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Distributors
11.3 Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Customer
12 WORLD FORECAST REVIEW FOR CHEMOTHERAPY INDUCED NAUSEA AND VOMITING (CINV) DRUGS BY GEOGRAPHIC REGION
12.1 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Size Forecast by Region
12.1.1 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Forecast by Region (2026-2031)
12.1.2 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Forecast by Type (2026-2031)
12.7 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Merck
13.1.1 Merck Company Information
13.1.2 Merck Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Product Portfolios and Specifications
13.1.3 Merck Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Merck Main Business Overview
13.1.5 Merck Latest Developments
13.2 Eisai
13.2.1 Eisai Company Information
13.2.2 Eisai Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Product Portfolios and Specifications
13.2.3 Eisai Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Eisai Main Business Overview
13.2.5 Eisai Latest Developments
13.3 Mundipharma
13.3.1 Mundipharma Company Information
13.3.2 Mundipharma Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Product Portfolios and Specifications
13.3.3 Mundipharma Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Mundipharma Main Business Overview
13.3.5 Mundipharma Latest Developments
13.4 Qilu Pharma
13.4.1 Qilu Pharma Company Information
13.4.2 Qilu Pharma Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Product Portfolios and Specifications
13.4.3 Qilu Pharma Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Qilu Pharma Main Business Overview
13.4.5 Qilu Pharma Latest Developments
13.5 Teva
13.5.1 Teva Company Information
13.5.2 Teva Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Product Portfolios and Specifications
13.5.3 Teva Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Teva Main Business Overview
13.5.5 Teva Latest Developments
13.6 Novartis
13.6.1 Novartis Company Information
13.6.2 Novartis Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Product Portfolios and Specifications
13.6.3 Novartis Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Novartis Main Business Overview
13.6.5 Novartis Latest Developments
13.7 Heron Therapeutics
13.7.1 Heron Therapeutics Company Information
13.7.2 Heron Therapeutics Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Product Portfolios and Specifications
13.7.3 Heron Therapeutics Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Heron Therapeutics Main Business Overview
13.7.5 Heron Therapeutics Latest Developments
13.8 Roche
13.8.1 Roche Company Information
13.8.2 Roche Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Product Portfolios and Specifications
13.8.3 Roche Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Roche Main Business Overview
13.8.5 Roche Latest Developments
13.9 Mylan
13.9.1 Mylan Company Information
13.9.2 Mylan Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Product Portfolios and Specifications
13.9.3 Mylan Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Mylan Main Business Overview
13.9.5 Mylan Latest Developments
13.10 Tesaro
13.10.1 Tesaro Company Information
13.10.2 Tesaro Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Product Portfolios and Specifications
13.10.3 Tesaro Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Tesaro Main Business Overview
13.10.5 Tesaro Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OFTABLES
Table 1. Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of 5-HT3 Inhibitors
Table 4. Major Players of NK1 Inhibitors
Table 5. Major Players of Other
Table 6. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales byType (2020-2025) & (K Units)
Table 7. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Market Share byType (2020-2025)
Table 8. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue byType (2020-2025) & ($ million)
Table 9. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Market Share byType (2020-2025)
Table 10. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sale Price byType (2020-2025) & (USD/Unit)
Table 11. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sale by Application (2020-2025) & (K Units)
Table 12. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sale Market Share by Application (2020-2025)
Table 13. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue by Application (2020-2025) & ($ million)
Table 14. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Market Share by Application (2020-2025)
Table 15. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sale Price by Application (2020-2025) & (USD/Unit)
Table 16. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Company (2020-2025) & (K Units)
Table 17. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Market Share by Company (2020-2025)
Table 18. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue by Company (2020-2025) & ($ millions)
Table 19. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Market Share by Company (2020-2025)
Table 20. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sale Price by Company (2020-2025) & (USD/Unit)
Table 21. Key Manufacturers Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Producing Area Distribution and Sales Area
Table 22. Players Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Products Offered
Table 23. Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 24. New Products and Potential Entrants
Table 25. Market M&A Activity & Strategy
Table 26. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Geographic Region (2020-2025) & (K Units)
Table 27. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Market Share Geographic Region (2020-2025)
Table 28. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue by Geographic Region (2020-2025) & ($ millions)
Table 29. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Market Share by Geographic Region (2020-2025)
Table 30. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Country/Region (2020-2025) & (K Units)
Table 31. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Market Share by Country/Region (2020-2025)
Table 32. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue by Country/Region (2020-2025) & ($ millions)
Table 33. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Market Share by Country/Region (2020-2025)
Table 34. Americas Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Country (2020-2025) & (K Units)
Table 35. Americas Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Market Share by Country (2020-2025)
Table 36. Americas Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue by Country (2020-2025) & ($ millions)
Table 37. Americas Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales byType (2020-2025) & (K Units)
Table 38. Americas Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Application (2020-2025) & (K Units)
Table 39. APAC Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Region (2020-2025) & (K Units)
Table 40. APAC Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Market Share by Region (2020-2025)
Table 41. APAC Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue by Region (2020-2025) & ($ millions)
Table 42. APAC Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales byType (2020-2025) & (K Units)
Table 43. APAC Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Application (2020-2025) & (K Units)
Table 44. Europe Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Country (2020-2025) & (K Units)
Table 45. Europe Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue by Country (2020-2025) & ($ millions)
Table 46. Europe Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales byType (2020-2025) & (K Units)
Table 47. Europe Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Application (2020-2025) & (K Units)
Table 48. Middle East & Africa Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Country (2020-2025) & (K Units)
Table 49. Middle East & Africa Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Market Share by Country (2020-2025)
Table 50. Middle East & Africa Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales byType (2020-2025) & (K Units)
Table 51. Middle East & Africa Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Application (2020-2025) & (K Units)
Table 52. Key Market Drivers & Growth Opportunities of Chemotherapy Induced Nausea and Vomiting (CINV) Drugs
Table 53. Key Market Challenges & Risks of Chemotherapy Induced Nausea and Vomiting (CINV) Drugs
Table 54. Key IndustryTrends of Chemotherapy Induced Nausea and Vomiting (CINV) Drugs
Table 55. Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Raw Material
Table 56. Key Suppliers of Raw Materials
Table 57. Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Distributors List
Table 58. Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Customer List
Table 59. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs SalesForecast by Region (2026-2031) & (K Units)
Table 60. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs RevenueForecast by Region (2026-2031) & ($ millions)
Table 61. Americas Chemotherapy Induced Nausea and Vomiting (CINV) Drugs SalesForecast by Country (2026-2031) & (K Units)
Table 62. Americas Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Annual RevenueForecast by Country (2026-2031) & ($ millions)
Table 63. APAC Chemotherapy Induced Nausea and Vomiting (CINV) Drugs SalesForecast by Region (2026-2031) & (K Units)
Table 64. APAC Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Annual RevenueForecast by Region (2026-2031) & ($ millions)
Table 65. Europe Chemotherapy Induced Nausea and Vomiting (CINV) Drugs SalesForecast by Country (2026-2031) & (K Units)
Table 66. Europe Chemotherapy Induced Nausea and Vomiting (CINV) Drugs RevenueForecast by Country (2026-2031) & ($ millions)
Table 67. Middle East & Africa Chemotherapy Induced Nausea and Vomiting (CINV) Drugs SalesForecast by Country (2026-2031) & (K Units)
Table 68. Middle East & Africa Chemotherapy Induced Nausea and Vomiting (CINV) Drugs RevenueForecast by Country (2026-2031) & ($ millions)
Table 69. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs SalesForecast byType (2026-2031) & (K Units)
Table 70. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs RevenueForecast byType (2026-2031) & ($ millions)
Table 71. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs SalesForecast by Application (2026-2031) & (K Units)
Table 72. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs RevenueForecast by Application (2026-2031) & ($ millions)
Table 73. Merck Basic Information, Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Manufacturing Base, Sales Area and Its Competitors
Table 74. Merck Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Product Portfolios and Specifications
Table 75. Merck Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 76. Merck Main Business
Table 77. Merck Latest Developments
Table 78. Eisai Basic Information, Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Manufacturing Base, Sales Area and Its Competitors
Table 79. Eisai Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Product Portfolios and Specifications
Table 80. Eisai Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 81. Eisai Main Business
Table 82. Eisai Latest Developments
Table 83. Mundipharma Basic Information, Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Manufacturing Base, Sales Area and Its Competitors
Table 84. Mundipharma Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Product Portfolios and Specifications
Table 85. Mundipharma Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 86. Mundipharma Main Business
Table 87. Mundipharma Latest Developments
Table 88. Qilu Pharma Basic Information, Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Manufacturing Base, Sales Area and Its Competitors
Table 89. Qilu Pharma Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Product Portfolios and Specifications
Table 90. Qilu Pharma Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 91. Qilu Pharma Main Business
Table 92. Qilu Pharma Latest Developments
Table 93.Teva Basic Information, Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Manufacturing Base, Sales Area and Its Competitors
Table 94.Teva Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Product Portfolios and Specifications
Table 95.Teva Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 96.Teva Main Business
Table 97.Teva Latest Developments
Table 98. Novartis Basic Information, Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Manufacturing Base, Sales Area and Its Competitors
Table 99. Novartis Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Product Portfolios and Specifications
Table 100. Novartis Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 101. Novartis Main Business
Table 102. Novartis Latest Developments
Table 103. HeronTherapeutics Basic Information, Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Manufacturing Base, Sales Area and Its Competitors
Table 104. HeronTherapeutics Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Product Portfolios and Specifications
Table 105. HeronTherapeutics Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 106. HeronTherapeutics Main Business
Table 107. HeronTherapeutics Latest Developments
Table 108. Roche Basic Information, Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Manufacturing Base, Sales Area and Its Competitors
Table 109. Roche Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Product Portfolios and Specifications
Table 110. Roche Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 111. Roche Main Business
Table 112. Roche Latest Developments
Table 113. Mylan Basic Information, Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Manufacturing Base, Sales Area and Its Competitors
Table 114. Mylan Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Product Portfolios and Specifications
Table 115. Mylan Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 116. Mylan Main Business
Table 117. Mylan Latest Developments
Table 118.Tesaro Basic Information, Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Manufacturing Base, Sales Area and Its Competitors
Table 119.Tesaro Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Product Portfolios and Specifications
Table 120.Tesaro Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 121.Tesaro Main Business
Table 122.Tesaro Latest Developments
LIST OFFIGURES
Figure 1. Picture of Chemotherapy Induced Nausea and Vomiting (CINV) Drugs
Figure 2. Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Growth Rate 2020-2031 (K Units)
Figure 7. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Market Share by Country/Region (2024)
Figure 10. Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of 5-HT3 Inhibitors
Figure 12. Product Picture of NK1 Inhibitors
Figure 13. Product Picture of Other
Figure 14. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Market Share byType in 2025
Figure 15. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Market Share byType (2020-2025)
Figure 16. Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumed in Highly Emetogenic Chemotherapy
Figure 17. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market: Highly Emetogenic Chemotherapy (2020-2025) & (K Units)
Figure 18. Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumed in Moderately Emetogenic Chemotherapy
Figure 19. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market: Moderately Emetogenic Chemotherapy (2020-2025) & (K Units)
Figure 20. Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumed in Low Emetogenic Chemotherapy
Figure 21. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market: Low Emetogenic Chemotherapy (2020-2025) & (K Units)
Figure 22. Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumed in Other
Figure 23. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market: Other (2020-2025) & (K Units)
Figure 24. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sale Market Share by Application (2024)
Figure 25. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Market Share by Application in 2025
Figure 26. Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Company in 2025 (K Units)
Figure 27. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Market Share by Company in 2025
Figure 28. Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue by Company in 2025 ($ millions)
Figure 29. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Market Share by Company in 2025
Figure 30. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Market Share by Geographic Region (2020-2025)
Figure 31. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Market Share by Geographic Region in 2025
Figure 32. Americas Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales 2020-2025 (K Units)
Figure 33. Americas Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue 2020-2025 ($ millions)
Figure 34. APAC Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales 2020-2025 (K Units)
Figure 35. APAC Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue 2020-2025 ($ millions)
Figure 36. Europe Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales 2020-2025 (K Units)
Figure 37. Europe Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue 2020-2025 ($ millions)
Figure 38. Middle East & Africa Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales 2020-2025 (K Units)
Figure 39. Middle East & Africa Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue 2020-2025 ($ millions)
Figure 40. Americas Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Market Share by Country in 2025
Figure 41. Americas Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Market Share by Country (2020-2025)
Figure 42. Americas Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Market Share byType (2020-2025)
Figure 43. Americas Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Market Share by Application (2020-2025)
Figure 44. United States Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Growth 2020-2025 ($ millions)
Figure 45. Canada Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Growth 2020-2025 ($ millions)
Figure 46. Mexico Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Growth 2020-2025 ($ millions)
Figure 47. Brazil Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Growth 2020-2025 ($ millions)
Figure 48. APAC Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Market Share by Region in 2025
Figure 49. APAC Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Market Share by Region (2020-2025)
Figure 50. APAC Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Market Share byType (2020-2025)
Figure 51. APAC Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Market Share by Application (2020-2025)
Figure 52. China Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Growth 2020-2025 ($ millions)
Figure 53. Japan Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Growth 2020-2025 ($ millions)
Figure 54. South Korea Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Growth 2020-2025 ($ millions)
Figure 55. Southeast Asia Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Growth 2020-2025 ($ millions)
Figure 56. India Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Growth 2020-2025 ($ millions)
Figure 57. Australia Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Growth 2020-2025 ($ millions)
Figure 58. ChinaTaiwan Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Growth 2020-2025 ($ millions)
Figure 59. Europe Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Market Share by Country in 2025
Figure 60. Europe Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Market Share by Country (2020-2025)
Figure 61. Europe Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Market Share byType (2020-2025)
Figure 62. Europe Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Market Share by Application (2020-2025)
Figure 63. Germany Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Growth 2020-2025 ($ millions)
Figure 64.France Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Growth 2020-2025 ($ millions)
Figure 65. UK Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Growth 2020-2025 ($ millions)
Figure 66. Italy Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Growth 2020-2025 ($ millions)
Figure 67. Russia Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Growth 2020-2025 ($ millions)
Figure 68. Middle East & Africa Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Market Share by Country (2020-2025)
Figure 69. Middle East & Africa Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Market Share byType (2020-2025)
Figure 70. Middle East & Africa Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Market Share by Application (2020-2025)
Figure 71. Egypt Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Growth 2020-2025 ($ millions)
Figure 72. South Africa Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Growth 2020-2025 ($ millions)
Figure 73. Israel Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Growth 2020-2025 ($ millions)
Figure 74.Turkey Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Growth 2020-2025 ($ millions)
Figure 75. GCC Countries Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Growth 2020-2025 ($ millions)
Figure 76. Manufacturing Cost Structure Analysis of Chemotherapy Induced Nausea and Vomiting (CINV) Drugs in 2025
Figure 77. Manufacturing Process Analysis of Chemotherapy Induced Nausea and Vomiting (CINV) Drugs
Figure 78. Industry Chain Structure of Chemotherapy Induced Nausea and Vomiting (CINV) Drugs
Figure 79. Channels of Distribution
Figure 80. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales MarketForecast by Region (2026-2031)
Figure 81. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Market ShareForecast by Region (2026-2031)
Figure 82. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Market ShareForecast byType (2026-2031)
Figure 83. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Market ShareForecast byType (2026-2031)
Figure 84. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Market ShareForecast by Application (2026-2031)
Figure 85. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Market ShareForecast by Application (2026-2031)
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Chemotherapy Induced Nausea and Vomiting (CINV) Drugs by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Chemotherapy Induced Nausea and Vomiting (CINV) Drugs by Country/Region, 2020, 2024 & 2031
2.2 Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Segment by Type
2.2.1 5-HT3 Inhibitors
2.2.2 NK1 Inhibitors
2.2.3 Other
2.3 Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Type
2.3.1 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Market Share by Type (2020-2025)
2.3.2 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue and Market Share by Type (2020-2025)
2.3.3 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sale Price by Type (2020-2025)
2.4 Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Segment by Application
2.4.1 Highly Emetogenic Chemotherapy
2.4.2 Moderately Emetogenic Chemotherapy
2.4.3 Low Emetogenic Chemotherapy
2.4.4 Other
2.5 Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Application
2.5.1 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sale Market Share by Application (2020-2025)
2.5.2 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue and Market Share by Application (2020-2025)
2.5.3 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Breakdown Data by Company
3.1.1 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Annual Sales by Company (2020-2025)
3.1.2 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Market Share by Company (2020-2025)
3.2 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Annual Revenue by Company (2020-2025)
3.2.1 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue by Company (2020-2025)
3.2.2 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Market Share by Company (2020-2025)
3.3 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sale Price by Company
3.4 Key Manufacturers Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Product Location Distribution
3.4.2 Players Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR CHEMOTHERAPY INDUCED NAUSEA AND VOMITING (CINV) DRUGS BY GEOGRAPHIC REGION
4.1 World Historic Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Size by Geographic Region (2020-2025)
4.1.1 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Size by Country/Region (2020-2025)
4.2.1 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Annual Sales by Country/Region (2020-2025)
4.2.2 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Annual Revenue by Country/Region (2020-2025)
4.3 Americas Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Growth
4.4 APAC Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Growth
4.5 Europe Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Growth
4.6 Middle East & Africa Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Growth
5 AMERICAS
5.1 Americas Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Country
5.1.1 Americas Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Country (2020-2025)
5.1.2 Americas Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue by Country (2020-2025)
5.2 Americas Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Type (2020-2025)
5.3 Americas Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Region
6.1.1 APAC Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Region (2020-2025)
6.1.2 APAC Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue by Region (2020-2025)
6.2 APAC Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Type (2020-2025)
6.3 APAC Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Chemotherapy Induced Nausea and Vomiting (CINV) Drugs by Country
7.1.1 Europe Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Country (2020-2025)
7.1.2 Europe Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue by Country (2020-2025)
7.2 Europe Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Type (2020-2025)
7.3 Europe Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Chemotherapy Induced Nausea and Vomiting (CINV) Drugs by Country
8.1.1 Middle East & Africa Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Country (2020-2025)
8.1.2 Middle East & Africa Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue by Country (2020-2025)
8.2 Middle East & Africa Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Type (2020-2025)
8.3 Middle East & Africa Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Chemotherapy Induced Nausea and Vomiting (CINV) Drugs
10.3 Manufacturing Process Analysis of Chemotherapy Induced Nausea and Vomiting (CINV) Drugs
10.4 Industry Chain Structure of Chemotherapy Induced Nausea and Vomiting (CINV) Drugs
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Distributors
11.3 Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Customer
12 WORLD FORECAST REVIEW FOR CHEMOTHERAPY INDUCED NAUSEA AND VOMITING (CINV) DRUGS BY GEOGRAPHIC REGION
12.1 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Size Forecast by Region
12.1.1 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Forecast by Region (2026-2031)
12.1.2 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Forecast by Type (2026-2031)
12.7 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Merck
13.1.1 Merck Company Information
13.1.2 Merck Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Product Portfolios and Specifications
13.1.3 Merck Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Merck Main Business Overview
13.1.5 Merck Latest Developments
13.2 Eisai
13.2.1 Eisai Company Information
13.2.2 Eisai Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Product Portfolios and Specifications
13.2.3 Eisai Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Eisai Main Business Overview
13.2.5 Eisai Latest Developments
13.3 Mundipharma
13.3.1 Mundipharma Company Information
13.3.2 Mundipharma Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Product Portfolios and Specifications
13.3.3 Mundipharma Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Mundipharma Main Business Overview
13.3.5 Mundipharma Latest Developments
13.4 Qilu Pharma
13.4.1 Qilu Pharma Company Information
13.4.2 Qilu Pharma Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Product Portfolios and Specifications
13.4.3 Qilu Pharma Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Qilu Pharma Main Business Overview
13.4.5 Qilu Pharma Latest Developments
13.5 Teva
13.5.1 Teva Company Information
13.5.2 Teva Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Product Portfolios and Specifications
13.5.3 Teva Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Teva Main Business Overview
13.5.5 Teva Latest Developments
13.6 Novartis
13.6.1 Novartis Company Information
13.6.2 Novartis Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Product Portfolios and Specifications
13.6.3 Novartis Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Novartis Main Business Overview
13.6.5 Novartis Latest Developments
13.7 Heron Therapeutics
13.7.1 Heron Therapeutics Company Information
13.7.2 Heron Therapeutics Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Product Portfolios and Specifications
13.7.3 Heron Therapeutics Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Heron Therapeutics Main Business Overview
13.7.5 Heron Therapeutics Latest Developments
13.8 Roche
13.8.1 Roche Company Information
13.8.2 Roche Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Product Portfolios and Specifications
13.8.3 Roche Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Roche Main Business Overview
13.8.5 Roche Latest Developments
13.9 Mylan
13.9.1 Mylan Company Information
13.9.2 Mylan Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Product Portfolios and Specifications
13.9.3 Mylan Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Mylan Main Business Overview
13.9.5 Mylan Latest Developments
13.10 Tesaro
13.10.1 Tesaro Company Information
13.10.2 Tesaro Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Product Portfolios and Specifications
13.10.3 Tesaro Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Tesaro Main Business Overview
13.10.5 Tesaro Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OFTABLES
Table 1. Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of 5-HT3 Inhibitors
Table 4. Major Players of NK1 Inhibitors
Table 5. Major Players of Other
Table 6. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales byType (2020-2025) & (K Units)
Table 7. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Market Share byType (2020-2025)
Table 8. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue byType (2020-2025) & ($ million)
Table 9. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Market Share byType (2020-2025)
Table 10. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sale Price byType (2020-2025) & (USD/Unit)
Table 11. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sale by Application (2020-2025) & (K Units)
Table 12. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sale Market Share by Application (2020-2025)
Table 13. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue by Application (2020-2025) & ($ million)
Table 14. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Market Share by Application (2020-2025)
Table 15. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sale Price by Application (2020-2025) & (USD/Unit)
Table 16. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Company (2020-2025) & (K Units)
Table 17. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Market Share by Company (2020-2025)
Table 18. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue by Company (2020-2025) & ($ millions)
Table 19. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Market Share by Company (2020-2025)
Table 20. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sale Price by Company (2020-2025) & (USD/Unit)
Table 21. Key Manufacturers Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Producing Area Distribution and Sales Area
Table 22. Players Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Products Offered
Table 23. Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 24. New Products and Potential Entrants
Table 25. Market M&A Activity & Strategy
Table 26. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Geographic Region (2020-2025) & (K Units)
Table 27. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Market Share Geographic Region (2020-2025)
Table 28. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue by Geographic Region (2020-2025) & ($ millions)
Table 29. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Market Share by Geographic Region (2020-2025)
Table 30. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Country/Region (2020-2025) & (K Units)
Table 31. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Market Share by Country/Region (2020-2025)
Table 32. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue by Country/Region (2020-2025) & ($ millions)
Table 33. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Market Share by Country/Region (2020-2025)
Table 34. Americas Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Country (2020-2025) & (K Units)
Table 35. Americas Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Market Share by Country (2020-2025)
Table 36. Americas Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue by Country (2020-2025) & ($ millions)
Table 37. Americas Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales byType (2020-2025) & (K Units)
Table 38. Americas Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Application (2020-2025) & (K Units)
Table 39. APAC Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Region (2020-2025) & (K Units)
Table 40. APAC Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Market Share by Region (2020-2025)
Table 41. APAC Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue by Region (2020-2025) & ($ millions)
Table 42. APAC Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales byType (2020-2025) & (K Units)
Table 43. APAC Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Application (2020-2025) & (K Units)
Table 44. Europe Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Country (2020-2025) & (K Units)
Table 45. Europe Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue by Country (2020-2025) & ($ millions)
Table 46. Europe Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales byType (2020-2025) & (K Units)
Table 47. Europe Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Application (2020-2025) & (K Units)
Table 48. Middle East & Africa Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Country (2020-2025) & (K Units)
Table 49. Middle East & Africa Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Market Share by Country (2020-2025)
Table 50. Middle East & Africa Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales byType (2020-2025) & (K Units)
Table 51. Middle East & Africa Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Application (2020-2025) & (K Units)
Table 52. Key Market Drivers & Growth Opportunities of Chemotherapy Induced Nausea and Vomiting (CINV) Drugs
Table 53. Key Market Challenges & Risks of Chemotherapy Induced Nausea and Vomiting (CINV) Drugs
Table 54. Key IndustryTrends of Chemotherapy Induced Nausea and Vomiting (CINV) Drugs
Table 55. Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Raw Material
Table 56. Key Suppliers of Raw Materials
Table 57. Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Distributors List
Table 58. Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Customer List
Table 59. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs SalesForecast by Region (2026-2031) & (K Units)
Table 60. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs RevenueForecast by Region (2026-2031) & ($ millions)
Table 61. Americas Chemotherapy Induced Nausea and Vomiting (CINV) Drugs SalesForecast by Country (2026-2031) & (K Units)
Table 62. Americas Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Annual RevenueForecast by Country (2026-2031) & ($ millions)
Table 63. APAC Chemotherapy Induced Nausea and Vomiting (CINV) Drugs SalesForecast by Region (2026-2031) & (K Units)
Table 64. APAC Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Annual RevenueForecast by Region (2026-2031) & ($ millions)
Table 65. Europe Chemotherapy Induced Nausea and Vomiting (CINV) Drugs SalesForecast by Country (2026-2031) & (K Units)
Table 66. Europe Chemotherapy Induced Nausea and Vomiting (CINV) Drugs RevenueForecast by Country (2026-2031) & ($ millions)
Table 67. Middle East & Africa Chemotherapy Induced Nausea and Vomiting (CINV) Drugs SalesForecast by Country (2026-2031) & (K Units)
Table 68. Middle East & Africa Chemotherapy Induced Nausea and Vomiting (CINV) Drugs RevenueForecast by Country (2026-2031) & ($ millions)
Table 69. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs SalesForecast byType (2026-2031) & (K Units)
Table 70. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs RevenueForecast byType (2026-2031) & ($ millions)
Table 71. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs SalesForecast by Application (2026-2031) & (K Units)
Table 72. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs RevenueForecast by Application (2026-2031) & ($ millions)
Table 73. Merck Basic Information, Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Manufacturing Base, Sales Area and Its Competitors
Table 74. Merck Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Product Portfolios and Specifications
Table 75. Merck Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 76. Merck Main Business
Table 77. Merck Latest Developments
Table 78. Eisai Basic Information, Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Manufacturing Base, Sales Area and Its Competitors
Table 79. Eisai Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Product Portfolios and Specifications
Table 80. Eisai Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 81. Eisai Main Business
Table 82. Eisai Latest Developments
Table 83. Mundipharma Basic Information, Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Manufacturing Base, Sales Area and Its Competitors
Table 84. Mundipharma Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Product Portfolios and Specifications
Table 85. Mundipharma Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 86. Mundipharma Main Business
Table 87. Mundipharma Latest Developments
Table 88. Qilu Pharma Basic Information, Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Manufacturing Base, Sales Area and Its Competitors
Table 89. Qilu Pharma Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Product Portfolios and Specifications
Table 90. Qilu Pharma Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 91. Qilu Pharma Main Business
Table 92. Qilu Pharma Latest Developments
Table 93.Teva Basic Information, Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Manufacturing Base, Sales Area and Its Competitors
Table 94.Teva Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Product Portfolios and Specifications
Table 95.Teva Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 96.Teva Main Business
Table 97.Teva Latest Developments
Table 98. Novartis Basic Information, Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Manufacturing Base, Sales Area and Its Competitors
Table 99. Novartis Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Product Portfolios and Specifications
Table 100. Novartis Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 101. Novartis Main Business
Table 102. Novartis Latest Developments
Table 103. HeronTherapeutics Basic Information, Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Manufacturing Base, Sales Area and Its Competitors
Table 104. HeronTherapeutics Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Product Portfolios and Specifications
Table 105. HeronTherapeutics Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 106. HeronTherapeutics Main Business
Table 107. HeronTherapeutics Latest Developments
Table 108. Roche Basic Information, Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Manufacturing Base, Sales Area and Its Competitors
Table 109. Roche Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Product Portfolios and Specifications
Table 110. Roche Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 111. Roche Main Business
Table 112. Roche Latest Developments
Table 113. Mylan Basic Information, Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Manufacturing Base, Sales Area and Its Competitors
Table 114. Mylan Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Product Portfolios and Specifications
Table 115. Mylan Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 116. Mylan Main Business
Table 117. Mylan Latest Developments
Table 118.Tesaro Basic Information, Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Manufacturing Base, Sales Area and Its Competitors
Table 119.Tesaro Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Product Portfolios and Specifications
Table 120.Tesaro Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 121.Tesaro Main Business
Table 122.Tesaro Latest Developments
LIST OFFIGURES
Figure 1. Picture of Chemotherapy Induced Nausea and Vomiting (CINV) Drugs
Figure 2. Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Growth Rate 2020-2031 (K Units)
Figure 7. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Market Share by Country/Region (2024)
Figure 10. Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of 5-HT3 Inhibitors
Figure 12. Product Picture of NK1 Inhibitors
Figure 13. Product Picture of Other
Figure 14. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Market Share byType in 2025
Figure 15. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Market Share byType (2020-2025)
Figure 16. Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumed in Highly Emetogenic Chemotherapy
Figure 17. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market: Highly Emetogenic Chemotherapy (2020-2025) & (K Units)
Figure 18. Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumed in Moderately Emetogenic Chemotherapy
Figure 19. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market: Moderately Emetogenic Chemotherapy (2020-2025) & (K Units)
Figure 20. Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumed in Low Emetogenic Chemotherapy
Figure 21. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market: Low Emetogenic Chemotherapy (2020-2025) & (K Units)
Figure 22. Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumed in Other
Figure 23. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market: Other (2020-2025) & (K Units)
Figure 24. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sale Market Share by Application (2024)
Figure 25. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Market Share by Application in 2025
Figure 26. Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Company in 2025 (K Units)
Figure 27. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Market Share by Company in 2025
Figure 28. Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue by Company in 2025 ($ millions)
Figure 29. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Market Share by Company in 2025
Figure 30. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Market Share by Geographic Region (2020-2025)
Figure 31. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Market Share by Geographic Region in 2025
Figure 32. Americas Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales 2020-2025 (K Units)
Figure 33. Americas Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue 2020-2025 ($ millions)
Figure 34. APAC Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales 2020-2025 (K Units)
Figure 35. APAC Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue 2020-2025 ($ millions)
Figure 36. Europe Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales 2020-2025 (K Units)
Figure 37. Europe Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue 2020-2025 ($ millions)
Figure 38. Middle East & Africa Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales 2020-2025 (K Units)
Figure 39. Middle East & Africa Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue 2020-2025 ($ millions)
Figure 40. Americas Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Market Share by Country in 2025
Figure 41. Americas Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Market Share by Country (2020-2025)
Figure 42. Americas Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Market Share byType (2020-2025)
Figure 43. Americas Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Market Share by Application (2020-2025)
Figure 44. United States Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Growth 2020-2025 ($ millions)
Figure 45. Canada Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Growth 2020-2025 ($ millions)
Figure 46. Mexico Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Growth 2020-2025 ($ millions)
Figure 47. Brazil Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Growth 2020-2025 ($ millions)
Figure 48. APAC Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Market Share by Region in 2025
Figure 49. APAC Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Market Share by Region (2020-2025)
Figure 50. APAC Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Market Share byType (2020-2025)
Figure 51. APAC Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Market Share by Application (2020-2025)
Figure 52. China Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Growth 2020-2025 ($ millions)
Figure 53. Japan Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Growth 2020-2025 ($ millions)
Figure 54. South Korea Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Growth 2020-2025 ($ millions)
Figure 55. Southeast Asia Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Growth 2020-2025 ($ millions)
Figure 56. India Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Growth 2020-2025 ($ millions)
Figure 57. Australia Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Growth 2020-2025 ($ millions)
Figure 58. ChinaTaiwan Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Growth 2020-2025 ($ millions)
Figure 59. Europe Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Market Share by Country in 2025
Figure 60. Europe Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Market Share by Country (2020-2025)
Figure 61. Europe Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Market Share byType (2020-2025)
Figure 62. Europe Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Market Share by Application (2020-2025)
Figure 63. Germany Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Growth 2020-2025 ($ millions)
Figure 64.France Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Growth 2020-2025 ($ millions)
Figure 65. UK Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Growth 2020-2025 ($ millions)
Figure 66. Italy Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Growth 2020-2025 ($ millions)
Figure 67. Russia Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Growth 2020-2025 ($ millions)
Figure 68. Middle East & Africa Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Market Share by Country (2020-2025)
Figure 69. Middle East & Africa Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Market Share byType (2020-2025)
Figure 70. Middle East & Africa Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Market Share by Application (2020-2025)
Figure 71. Egypt Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Growth 2020-2025 ($ millions)
Figure 72. South Africa Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Growth 2020-2025 ($ millions)
Figure 73. Israel Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Growth 2020-2025 ($ millions)
Figure 74.Turkey Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Growth 2020-2025 ($ millions)
Figure 75. GCC Countries Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Growth 2020-2025 ($ millions)
Figure 76. Manufacturing Cost Structure Analysis of Chemotherapy Induced Nausea and Vomiting (CINV) Drugs in 2025
Figure 77. Manufacturing Process Analysis of Chemotherapy Induced Nausea and Vomiting (CINV) Drugs
Figure 78. Industry Chain Structure of Chemotherapy Induced Nausea and Vomiting (CINV) Drugs
Figure 79. Channels of Distribution
Figure 80. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales MarketForecast by Region (2026-2031)
Figure 81. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Market ShareForecast by Region (2026-2031)
Figure 82. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Market ShareForecast byType (2026-2031)
Figure 83. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Market ShareForecast byType (2026-2031)
Figure 84. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Market ShareForecast by Application (2026-2031)
Figure 85. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Market ShareForecast by Application (2026-2031)
